Johnson & Johnson
Holdings as of Sep 30, 2026 · filed Oct 26, 2026
| # | Holding | Value | % Port. | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Protagonist Therapeutics Inc | $345065393 | 45.30% | — | Held |
| 2 | Nanobiotix | $175238107 | 23.01% | — | Held |
| 3 | Meiragtx Hldgs Plc | $73051704 | 9.59% | — | Held |
| 4 | Rapport Therapeutics Inc | $59959771 | 7.87% | — | Held |
| 5 | Contineum Therapeutics Inc | $26560502 | 3.49% | — | Held |
| 6 | Cerebras Systems Inc | $22854495 | 3.00% | +75063 | +140.08% |
| 7 | Xencor Inc | $18664147 | 2.45% | — | Held |
| 8 | Legend Biotech Corp | $16202116 | 2.13% | — | Held |
| 9 | Fate Therapeutics Inc | $8008382 | 1.05% | — | Held |
| 10 | Cvrx Inc | $7043507 | 0.92% | — | Held |
| 11 | Procept Biorobotics Corp | $6521649 | 0.86% | — | Held |
| 12 | Neumora Therapeutics Inc. | $1102639 | 0.14% | — | Held |
| 13 | Vor Biopharma Inc | $1025207 | 0.13% | — | Held |
| 14 | Standard Biotools Inc | $231043 | 0.03% | — | Held |
| 15 | Adicet Bio Inc | $162642 | 0.02% | — | Held |
Holdings disclosed quarterly to the SEC on Form 13-F and may be up to 45 days old. Values as reported. For research only — not investment advice.